We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 10,000 results
  1. Ten-year retrospect of the investigation of proximal limbs metastasis in cancer: a multi-center study on survival outcome, limb function status and surgical procedures analysis

    Background

    The aim of study was to evaluate survival outcome and limb function in cancer patients with proximal limbs metastasis. Associated factors...

    Chao Zhang, Jun Wang, ... Zheng Liu in BMC Cancer
    Article Open access 24 August 2023
  2. Nanoparticle pre-treatment for enhancing the survival and activation of pulmonary macrophage transplant

    Despite recent clinical successes of chimeric antigen receptor T cell therapies in treating liquid cancers, many lingering challenges stand in the...

    Bader M. Jarai, Kartik Bomb, Catherine A. Fromen in Drug Delivery and Translational Research
    Article Open access 14 March 2023
  3. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer

    Background

    Sarcopenic obesity arises from increased muscle catabolism triggered by inflammation and inactivity. Its significance lies in its role in...

    Muzaffer Ece Hakan Şahin, Feray Akbaş, ... Eren Şahin in BMC Cancer
    Article Open access 28 September 2023
  4. Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan

    Background

    Taiwan’s National Health Insurance has covered targeted therapy, namely cetuximab, for locally advanced head and neck cancers (LAHNC) since...

    Szu-Han Hu, Ming-Yii Huang, ... Hui-Min Hsieh in BMC Cancer
    Article Open access 20 June 2023
  5. Systemic therapy and radiotherapy related complications and subsequent hospitalisation rates: a systematic review

    Background

    Hospitalisation  resulting from complications of systemic therapy and radiotherapy places a substantial burden on the patient, society, and...

    Rashidul Alam Mahumud, Md. Shahjalal, ... Olivia Wawryk in BMC Cancer
    Article Open access 10 July 2024
  6. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures

    Purpose

    To construct machine learning models for predicting progression free survival (PFS) and overall survival (OS) with esophageal squamous cell...

    Yongbin Cui, Zhengjiang Li, ... Changsheng Ma in Radiation Oncology
    Article Open access 27 December 2022
  7. Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide study

    Background

    The coronavirus disease 2019 (COVID-19) severely hindered the timely receipt of health care for patients with cancer, especially female...

    Yu Min, Zheran Liu, ... **ngchen Peng in Journal of Translational Medicine
    Article Open access 03 December 2022
  8. Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting

    Background

    Small-cell lung cancer (SCLC) is a malignant tumor known for its poor prognosis. In addition to chemotherapy and immunotherapy irradiation...

    Marie-Theres Kassik, Dirk Vordermark, ... Daniel Medenwald in Radiation Oncology
    Article Open access 18 April 2023
  9. One year overall survival of wilms tumor cases and its predictors, among children diagnosed at a teaching hospital in South Western Uganda: a retrospective cohort study

    Background

    Wilms tumor (WT) is the second most common solid tumor in Africa with both low overall survival (OS) and event-free survival (EFS) rates....

    Eddymond Ekuk, Charles Newton Odongo, ... Martin Situma in BMC Cancer
    Article Open access 02 March 2023
  10. β-Catenin promotes long-term survival and angiogenesis of peripheral blood mesenchymal stem cells via the Oct4 signaling pathway

    Stem cell therapy has been extensively studied to improve heart function following myocardial infarction; however, its therapeutic potency is limited...

    Pengzhen Wang, Zhanyu Deng, ... Shaoheng Zhang in Experimental & Molecular Medicine
    Article Open access 01 September 2022
  11. Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer

    Epithelial-mesenchymal transition (EMT) is a crucial mechanism that facilitates cancer cell metastasis. Despite its importance, the clinical...

    Masanori Oshi, Arya Mariam Roy, ... Itaru Endo in Cancer Gene Therapy
    Article 26 March 2024
  12. Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma

    Targeting protein for Xenopus kinesin-like protein 2 (TPX2), a well-known mitotic protein, has been linked to carcinogenesis in several cancers. This...

    Weibin Zhang, Jia Dong, ... Liming Wang in Biochemical Genetics
    Article Open access 04 June 2024
  13. Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis

    Background

    We report here the first population-based incidence rates and prognosis of primary central nervous system lymphoma (PCNSL) in Finland.

    ...
    Inka Puhakka, Hanne Kuitunen, ... Outi Kuittinen in BMC Cancer
    Article Open access 03 March 2022
  14. Investigating the role of county-level colorectal cancer screening rates on stage at diagnosis of colorectal cancer in rural Georgia

    Background

    To examine the impact of county-level colorectal cancer (CRC) screening rates on stage at diagnosis of CRC and identify factors associated...

    Meng-Han Tsai, Steven S. Coughlin in Cancer Causes & Control
    Article 08 April 2024
  15. Cancer-specific survival in patients with cholangiocarcinoma after radical surgery: a Novel, dynamic nomogram based on clinicopathological features and serum markers

    Background

    This study aims to (1) identify preoperative testing-based characteristics associated with enhanced prognosis and survival for...

    Shurui Zhou, Yue Zhao, ... Kaihong Huang in BMC Cancer
    Article Open access 12 June 2023
  16. Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy

    Background

    Recurrent esophageal cancer is associated with dismal prognosis. There is no consensus about the role of surgical treatments in patients...

    **-Chung Tsai, Hung-Che Chien, ... Han-Shui Hsu in BMC Cancer
    Article Open access 09 June 2022
  17. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms

    Current therapies for high-grade TP53 -mutated myeloid neoplasms (≥10% blasts) do not offer a meaningful survival benefit except allogeneic stem cell...

    Amandeep Kaur, Alexandra E. Rojek, ... Girish Venkataraman in Blood Cancer Journal
    Article Open access 18 June 2024
  18. Elective nodal irradiation versus involved-field irradiation for stage II–IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes

    Background

    Definitive concurrent chemoradiotherapy (dCCRT) is suggested as the standard treatment for cervical esophageal squamous cell carcinoma...

    Jianing Wang, Ya**g Wu, ... Xueying Qiao in Radiation Oncology
    Article Open access 28 August 2023
  19. Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020

    Background

    Lung cancer is the third most frequent tumor and the main cause of death by tumor in Spain. Although the incidence and mortality are still...

    Abraham Galindo-Utrero, Jesús María San-Román-Montero, ... Ángel Gil-de-Miguel in BMC Cancer
    Article Open access 21 November 2022
  20. Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target

    Molecular markers for predicting prognosis of colorectal cancer (CRC) patients are urgently needed for effective disease management. We reported...

    Patrizia Malkomes, Ilaria Lunger, ... Michael A. Rieger in Cancer Gene Therapy
    Article Open access 13 July 2023
Did you find what you were looking for? Share feedback.